Archives of Toxicology

, Volume 54, Issue 1, pp 71–82 | Cite as

Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration

  • R. A. Braeckman
  • F. Audenaert
  • J. L. Willems
  • F. M. Belpaire
  • M. G. Bogaert
Original Investigations


Methyl parathion (20 mg · kg−1 intravenously and orally) and parathion (5 mg · kg−1 intravenously and 10 mg · kg−1 orally) were given to non-anesthetized dogs and the serum concentrations were followed in function of time. For both substances a low bioavailability after oral administration was found.

In other dogs radioactivity was followed in urine after oral and after intravenous administration of labeled methyl parathion or parathion. The results suggest a good gastro-intestinal absorption of the substances.

In anesthetized dogs which were given methyl parathion or parathion intravenously, high hepatic extraction ratios were found, suggesting that the low systemic availability after oral administration can be explained by an important hepatic first-pass extraction.

Binding of methyl parathion and parathion to dog serum, to human serum and to a solution of human albumin was determined with equilibrium dialysis. In both species a high binding (>90%) was found for both substances and there was no concentration-dependency in the concentration range used (0.2–30 μg · ml−1). In man and in dog the serum protein binding of parathion was about 5% higher than that of methyl parathion.

Key words

Organophosphates Dogs Methyl parathion Parathion Systemic availability First-pass Protein binding 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baker SR, McGilliard AD, Dahm PA (1979) Uptake, clearance and metabolism of parathion by perfused whole pig livers. Pestic Biochem Physiol 11: 20–32CrossRefGoogle Scholar
  2. Belpaire FM, Bogaert MG, Rosseneu M (1982) Binding of β-adrenoceptor blocking drugs to human serum albumin, to α 1-acid glycoprotein and to human serum. Eur J Clin Pharamacol 22: 253–256CrossRefGoogle Scholar
  3. Braeckman RA, Godefroot MG, Blondeel GM, Belpaire FM, Willems JL (1980) Kinetic analysis of the fate of methyl parathion in the dog. Arch Toxicol 43: 263–271CrossRefGoogle Scholar
  4. Eto M (1974) Organophosphorus pesticides: organic and biological chemistry. CRC Press Inc, ClevelandGoogle Scholar
  5. Fuhremann TW, Lichtenstein EP, Zahlten RN, Stratman FW, Schnoes HK (1974) Metabolism of [14C] parathion and [14C] paraoxon in isolated, perfused rat livers. Pestic Sci 5: 31–39CrossRefGoogle Scholar
  6. Gilette JR (1971) Factors affecting drug metabolism. Ann NY Acad Sci 179: 43–66CrossRefGoogle Scholar
  7. Hollingworth RM, Metcalf RL, Fukuto TR (1967) The selectivity of sumithion compared with methylparathion. Metabolism in the white mouse. J Agric Food Chem 15: 242–249CrossRefGoogle Scholar
  8. Luzhnikov EA, Yaroslavsky AA, Molodenkov MN, Shurlakin BK, Evseev NG, Barsukov UF (1977) Plasma perfusion through charcoal in methylparathion poisoning. Lancet 1: 38–39CrossRefGoogle Scholar
  9. Maliwal BP, Guthrie FE (1981) Interaction of insecticides with human serum albumin. Mol Pharmacol 20: 138–144PubMedGoogle Scholar
  10. Miyamoto J, Sato Y, Kadota T, Fujinami A, Endo M (1963) Studies on the mode of action of organophosphorus compounds. Part I. metabolic fate of 32P labeled sumithion and methylparathion in guinea pig and white rat. Agric Biol Chem 27: 381–389Google Scholar
  11. Mourik J, de Jong LPA (1978) Binding of the organophosphates parathion and paraoxon to bovine and human serum albumin. Arch Toxicol 41: 43–48CrossRefGoogle Scholar
  12. Nakatsugawa T, Tolman NM, Dahm PA (1969) Degradation of parathion in the rat. Biochem Pharmacol 18: 1103–1114CrossRefGoogle Scholar
  13. Neal RA (1972) A comparison of the in vitro metabolism of parathion in the lung and liver of the rabbit. Toxicol Appl Pharmacol 23: 123–130CrossRefGoogle Scholar
  14. Okonek S (1976) Probable progress in the therapy of organophosphate poisoning. Extracorporeal hemodialysis and hemoperfusion. Arch Toxicol 35: 221–227CrossRefGoogle Scholar
  15. Okonek S (1978) Elimination of parathion by hemoperfusion in severe E605 forte intoxication in vivo. Arch Pharmacol 302: R66Google Scholar
  16. Okonek S, Boelcke G, Hollmann H (1976) Therapeutic properties of haemodialysis and blood exchange transfusion in organophosphate poisoning. Eur J Int Care Med 2: 13–18CrossRefGoogle Scholar
  17. Pond S, Rosenberg J, Benowitz NL, Takki S (1979) Pharmacokinetics of haemoperfusion for drug overdose. Clin Pharmacokin 4: 329–354CrossRefGoogle Scholar
  18. Poore RE, Neal RA (1972) Evidence for extrahepatic metabolism of parathion. Toxicol Appl Pharmacol 23: 759–768CrossRefGoogle Scholar
  19. Skalsky HL, Guthrie FE (1977) Affinities of parathion, ddt, dieldrin and carbaryl for macromolecules in the blood of the rat and American cockroach and the competitive interaction of steroids. Pestic Biochem Physiol 7: 289–296CrossRefGoogle Scholar
  20. Tilstone WJ, Winchester JF, Reavey PC (1979) Pharmacokinetic concepts. The use of pharmacokinetic principles in determining the effectiveness of removal of toxins from blood. Clin Pharmacokin 4: 23–37CrossRefGoogle Scholar
  21. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, IllinoisGoogle Scholar
  22. Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • R. A. Braeckman
    • 1
  • F. Audenaert
    • 1
  • J. L. Willems
    • 2
  • F. M. Belpaire
    • 1
  • M. G. Bogaert
    • 1
  1. 1.Heymans Institute of PharmacologyUniversity of Gent Medical SchoolGent
  2. 2.Technical Division of the ArmyLaboratory of Medical ToxicologyPeutieBelgium

Personalised recommendations